– DIOSynVax anuncia un nuevo Consejo Asesor para impulsar el desarrollo clínico de sus vacunas contra la gripe NextGen, incluida la vacuna contra la gripe aviar CAMBRIDGE, Inglaterra y SAN DIEGO, 9 de enero de 2025 /PRNewswire/ — DIOSynVax, una empresa de biotecnología en etapa clínica a…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.